ATXIOTCPharmaceutical PreparationsFiscal year ends December 31
AVENUE THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.43+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $1.42M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 26, 2024 | 1-for-75 reverse | Earlier per-share figures multiplied by 75 |
| Mar 31, 2024 | 1-for-75 reverse | Earlier per-share figures multiplied by 75 |
| Sep 23, 2022 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Sep 23, 2022 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Aug 11, 2017(first seen in filings) | 1-for-3 reverse | Earlier per-share figures multiplied by 3 |